Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGO PEN: Intravenous Penicillin as an Adjunct to Oral Penicillin in Tonsillar Infections
NCT07896226Phase 4Recruiting
- Sponsor
- Gubra
- Start
- Nov 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of benzylpenicillin in acute tonsillitis, peritonsillar cellulitis, peritonsillar abscess (PTA), sponsored by Gubra. Started Nov 2026; status: recruiting.
02
Drugs
benzylpenicillin
03
Conditions
acute tonsillitisperitonsillar cellulitisperitonsillar abscess (PTA)
Beyond the preview
Go deeper on NCT07896226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07896226.